Uterine, Endometrial, Ovarian, and Cervical Cancer: Epidemiology and Treatment Strategies
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Obstetrics & Gynecology".
Deadline for manuscript submissions: closed (30 April 2024) | Viewed by 3978
Special Issue Editors
Interests: gynecologic oncology
Special Issue Information
Dear Colleagues,
Gynecological cancers including cervical cancer, endometrial cancer, and ovarian cancer have unique disease properties. Treatment for early-stage cervical or endometrial cancer almost always involves using minimally invasive surgery (MIS); laparoscopic surgery and robotic surgery have exhibited pronounced development, and the improvement of the safety of these surgeries is crucial for patients. Another focus on endometrial cancer is a different strategy associated with molecular classification. In ovarian cancer, recent molecular and genetic analysis is remarkable, and adjuvant chemotherapy for ovarian cancer is completely different from that of ten years ago. Artificial intelligence (AI) modalities might extend and expand human intelligence, and the diagnostic significance of AI technology is steadily progressing. Another remarkable issue related to gynecological cancer is the finding of gene fusions that are thought to be driver mutations. The oncology panel is developed and should be a promising candidate modality to find suitable drugs for unusual gynecologic tumors.
In this Special Issue, the authors will present the most recent studies concerning the development of gynecological cancers. These include treatment strategies for various gynecological cancers and the molecular characterization and prognostic parameters of gynecological cancers. We welcome the submission of novel research to help researchers and women who have an interest in gynecologic cancers to learn more about these diseases (symptoms, prevention, and early diagnosis), and improve their treatment.
Prof. Dr. Taek Sang Lee
Prof. Dr. Sung Jong Lee
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.